Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:733-738

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, B. S.
Right arrow Articles by Leenen, F. H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, B. S.
Right arrow Articles by Leenen, F. H. H.

(Hypertension. 1999;34:733-738.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Digoxin Prevents Ouabain and High Salt Intake–Induced Hypertension in Rats With Sinoaortic Denervation

Bing S. Huang; Marian Kudlac; Raj Kumarathasan; Frans H. H. Leenen

From the University of Ottawa Heart Institute, Ottawa, Ontario, Canada. R.K. was supported by the MRC/PMAC (Pfizer Canada) Program. F.H.H.L. is a career investigator of the Heart and Stroke Foundation of Ontario, Canada.

Correspondence to Frans H. H. Leenen, MD, PhD, FRCPC, Hypertension Unit, H360, Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin St, Ottawa, Ontario K1Y 4W7, Canada. E-mail fleenen{at}ottawaheart.ca

Abstract—Digoxin prevents ouabain-induced hypertension in rats. In the present study, we tested whether this effect of digoxin depends on its sensitizing effect on baroreflex function or is due to an antagonistic action on exogenous ouabain or endogenous ouabainlike activity ("ouabain") in the brain. In Wistar rats, resting mean arterial pressure (MAP) was significantly increased by long-term subcutaneous (SC) ouabain (75 µg/d) plus high salt (8%) intake for 12 days (but not after only 5 days). In rats with chronic sinoaortic denervation (SAD), MAP was increased within 5 days of ouabain treatment to the same extent as MAP after 12 days of treatment in intact rats. The effect of ouabain and high salt was prevented when digoxin was given SC concomitantly via osmotic minipump (200 µg · kg-1 · d-1). Resting MAP was not changed in rats treated with digoxin alone. In a second set of rats with chronic SAD or sham surgery, high salt intake was given for 14 days, with or without SC digoxin (200 µg · kg-1 · d-1) or intracerebroventricular (ICV) antibody Fab fragments (200 µg/d), which bind "ouabain" with high affinity. On day 14, MAP, central venous pressure, heart rate, and renal sympathetic nerve activity were recorded in conscious rats at rest and in response to air-jet stress, IV phenylephrine and nitroprusside, and acute volume expansion with 5% dextrose IV. In rats with SAD versus sham surgery, high salt significantly increased resting MAP as well as excitatory responses of MAP, heart rate, and renal sympathetic nerve activity to air stress. These effects of high salt in rats with SAD were prevented by digoxin or Fab fragments. Arterial baroreflex function was blunted but cardiopulmonary baroreflex function was not affected in rats with SAD. Digoxin and Fab fragments had no effects on either function. In an in vitro assay for the inhibitory effects on Na+,K+-ATPase activity, 20 ng of ouabain caused 29% inhibition, but 20 ng of ouabain plus 13 or 53 ng of digoxin caused only 16% or 4% inhibition, respectively. These data indicate that the arterial baroreflex opposes sympathoexcitatory responses to ouabain and "ouabain" in the brain, thereby delaying ouabain- and preventing high salt–induced hypertension in Wistar rats. In addition to possible effects on the arterial baroreflex, digoxin appears to act centrally to prevent the sympathoexcitatory and pressor effects of increased brain "ouabain" or ouabain.


Key Words: digoxin • nerve activity, sympathetic, renal • sodium intake • baroreflex • ouabain • denervation, sinoaortic • stress, air • Fab




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Zhang, J. M. Hamlyn, E. Karashima, H. Raina, J. R. H. Mauban, M. Izuka, R. Berra-Romani, A. Zulian, W. G. Wier, and M. P. Blaustein
Low-dose ouabain constricts small arteries from ouabain-hypertensive rats: implications for sustained elevation of vascular resistance
Am J Physiol Heart Circ Physiol, September 1, 2009; 297(3): H1140 - H1150.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. Y. Bagrov, J. I. Shapiro, and O. V. Fedorova
Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets
Pharmacol. Rev., March 1, 2009; 61(1): 9 - 38.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. P. Blaustein, J. Zhang, L. Chen, H. Song, H. Raina, S. P. Kinsey, M. Izuka, T. Iwamoto, M. I. Kotlikoff, J. B. Lingrel, et al.
The Pump, the Exchanger, and Endogenous Ouabain: Signaling Mechanisms That Link Salt Retention to Hypertension
Hypertension, February 1, 2009; 53(2): 291 - 298.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
W. Schoner and G. Scheiner-Bobis
Role of endogenous cardiotonic steroids in sodium homeostasis
Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2723 - 2729.
[Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. Feldmann, V. Glukmann, E. Medvenev, U. Shpolansky, D. Galili, D. Lichtstein, and H. Rosen
Role of endosomal Na+-K+-ATPase and cardiac steroids in the regulation of endocytosis
Am J Physiol Cell Physiol, September 1, 2007; 293(3): C885 - C896.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
W. Schoner and G. Scheiner-Bobis
Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth
Am J Physiol Cell Physiol, August 1, 2007; 293(2): C509 - C536.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. Bauer, J. Muller-Ehmsen, U. Kramer, N. Hambarchian, C. Zobel, R. H.G. Schwinger, H. Neu, U. Kirch, E.-G. Grunbaum, and W. Schoner
Ouabain-Like Compound Changes Rapidly on Physical Exercise in Humans and Dogs: Effects of {beta}-Blockade and Angiotensin-Converting Enzyme Inhibition
Hypertension, May 1, 2005; 45(5): 1024 - 1028.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. Dostanic, R. J. Paul, J. N. Lorenz, S. Theriault, J. W. Van Huysse, and J. B. Lingrel
The {alpha}2-isoform of Na-K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro
Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H477 - H485.
[Abstract] [Full Text] [PDF]